Aug 29, 2019

WHO conducts a Prequalification of Medicines Programme

WHO Prequalification of Medicines Programme is a service that is provided by WHO to evaluate the quality, safety and effectiveness of drugs. Manufacturers who have undergone a prequalification may participate in the supply of medicines to other countries with limited resources, which is carried out by WHO.

For prequalification, manufacturers must go through five stages:

  1. Apply for interest in evaluating the product. To do this, the medicine must be included in the WHO Model List of Essential Medicines, or be at the stage of application for inclusion in this list, or recommended for use by one of the existing WHO treatment facilities.
  2. Provide a dossier of the medicinal product – full information about the quality, safety and effectiveness of the product.
  3. Undergo an assessment by WHO specialists and experts from national regulatory authorities in different countries.
  4. Pass a production inspection that will verify compliance with WHO Good Manufacturing Practice (GMP), and WHO Good Clinical Practice (GCP) and Good Laboratory Practice (GLP).
  5. Get a decision.

The activities of the Prequalification Programme are based on international pharmaceutical standards of quality, safety and efficacy of medicines. In the long run, its goal is to increase access to medicines of assured quality by helping manufacturers to ensure compliance with WHO standards and supporting regulatory authorities to comply with them. In addition to evaluation and inspection activities, the Prequalification Programme creates national potential for sustainable production and monitoring of quality medicines by organizing training and transferring direct experience at the country level. The program also provides targeted technical assistance to manufacturers and quality control laboratories.

Back to the News